Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.

Oct 19, 2018

Amyris Successfully Producing its New Zero Calorie Natural Sweetener at Industrial Scale

EMERYVILLE, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, is pleased to announce that industrial scale production of what it believes is the world’s best tasting and lowest cost zero calorie natural sweetener has started and is successfully operating as expected.

The new sweetener product, derived from sugarcane, has been met with an overwhelmingly positive response by market leaders in the sweetener space. Amyris recently signed its first major supply and distribution agreement for its sweetener with ASR Group, the world’s largest cane sugar refiner and expects other agreements to follow very soon. The company is on track to meet all customer shipments for the product this year and expects to make and ship significant commercial tonnage this year.

“Our team has done an incredible job successfully scaling our technology to produce what we believe to be the world’s leading natural sweetener,” said Amyris President & CEO John Melo. “The industrialization of this technology has included building a full scale downstream process facility, developing a strain that makes natural sweetener from sugar cane syrup and adapting our industrial fermentation to produce the lowest cost natural sweetener available. Our partners and customers including ASR, the leading sweetener solution company in the US, are very excited about our progress and ready to provide consumers with a healthy sweetener solution.”

About Amyris

Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise™ products and services across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events, such as expected production and shipments of, agreements relating to, and the anticipated qualities of, Amyris’s new sweetener product. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to Amyris's liquidity and ability to fund operating and capital expenses, potential delays or failures in development, production and commercialization of products, risks related to Amyris's reliance on third parties, and other risks detailed from time to time in filings Amyris makes with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Amyris disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events, or otherwise.

Amyris, the Amyris logo and No Compromise are trademarks or registered trademarks of Amyris, Inc. in the U.S. and other countries. All other trademarks are the property of their respective owners.

Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@amyris.com